Virus-specific antibody indices may supplement the total IgG index in diagnostics of multiple sclerosis

[1]  S. Elledge,et al.  Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis , 2022, Science.

[2]  K. Ruprecht,et al.  Parvovirus B19 and mumps virus antibodies are major constituents of the intrathecal immune response in European patients with MS and increase the diagnostic sensitivity and discriminatory power of the MRZ reaction , 2021, Journal of Neurology.

[3]  J. Frederiksen,et al.  Epstein-Barr Virus and Multiple Sclerosis , 2020, Frontiers in Immunology.

[4]  J. Frederiksen,et al.  Antibodies to Epstein-Barr virus and neurotropic viruses in multiple sclerosis and optic neuritis , 2020, Journal of Neuroimmunology.

[5]  S. Verma,et al.  Role of Viruses in the Pathogenesis of Multiple Sclerosis , 2020, Viruses.

[6]  J. Yélamos,et al.  Impact of cytomegalovirus infection on B cell differentiation and cytokine production in multiple sclerosis , 2020, Journal of Neuroinflammation.

[7]  D. Donati.  Viral infections and multiple sclerosis , 2020, Drug Discovery Today: Disease Models.

[8]  E. Celius,et al.  The diagnostic value of IgG index versus oligoclonal bands in cerebrospinal fluid of patients with multiple sclerosis , 2020, Multiple sclerosis journal - experimental, translational and clinical.

[9]  P. Stys,et al.  Recent advances in understanding multiple sclerosis , 2019, F1000Research.

[10]  P. Calabresi,et al.  Cerebrospinal fluid free light chains compared to oligoclonal bands as biomarkers in multiple sclerosis , 2019, Journal of Neuroimmunology.

[11]  M. Martinetti,et al.  The Involvement of HLA Class II Alleles in Multiple Sclerosis: A Systematic Review with Meta-analysis , 2019, Disease markers.

[12]  M. Plebani,et al.  Free light chains in cerebrospinal fluid of multiple sclerosis patients negative for IgG oligoclonal bands , 2019 .

[13]  H. Zetterberg,et al.  The Cerebrospinal Fluid in Multiple Sclerosis , 2019, Front. Immunol..

[14]  G. Giovannoni,et al.  Multiple sclerosis – a review , 2018, European journal of neurology.

[15]  C. Mhiri,et al.  The intrathecal polyspecific antiviral immune response (MRZ reaction): A potential cerebrospinal fluid marker for multiple sclerosis diagnosis , 2018, Journal of Neuroimmunology.

[16]  À. Rovira,et al.  The value of oligoclonal bands in the multiple sclerosis diagnostic criteria , 2018, Brain : a journal of neurology.

[17]  R. Alroughani,et al.  Pediatric multiple sclerosis: a review , 2018, BMC Neurology.

[18]  K. Ruprecht,et al.  Low intrathecal antibody production despite high seroprevalence of Epstein–Barr virus in multiple sclerosis: a review of the literature , 2018, Journal of Neurology.

[19]  David H. Miller,et al.  Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria , 2017, The Lancet Neurology.

[20]  R. Dersch,et al.  The MRZ reaction in primary progressive multiple sclerosis , 2017, Fluids and Barriers of the CNS.

[21]  A. Damasceno,et al.  MRZH reaction increases sensitivity for intrathecal IgG synthesis in IgG Oligoclonal band negative Multiple Sclerosis patients , 2016, Journal of Neuroimmunology.

[22]  S. Yousefzadeh-Chabok,et al.  Prevalence of Cytomegalovirus in Patients With Multiple Sclerosis: A Case-Control Study in Northern Iran , 2016, Jundishapur journal of microbiology.

[23]  K. Ruprecht,et al.  Antibody producing B lineage cells invade the central nervous system predominantly at the time of and triggered by acute Epstein-Barr virus infection: A hypothesis on the origin of intrathecal immunoglobulin synthesis in multiple sclerosis. , 2016, Medical hypotheses.

[24]  M. Buttmann,et al.  Intrathecal, Polyspecific Antiviral Immune Response in Oligoclonal Band Negative Multiple Sclerosis , 2012, PloS one.

[25]  A. Odén,et al.  The effect of live, attenuated measles vaccine and measles infection on measles antibody levels in serum and CSF of patients with multiple sclerosis or clinically isolated syndrome , 2011, Journal of Neuroimmunology.

[26]  A. Ludolph,et al.  IgG Antibodies against Measles, Rubella, and Varicella Zoster Virus Predict Conversion to Multiple Sclerosis in Clinically Isolated Syndrome , 2009, PloS one.

[27]  J. Lünemann,et al.  BROADENED AND ELEVATED HUMORAL IMMUNE RESPONSE TO EBNA1 IN PEDIATRIC MULTIPLE SCLEROSIS , 2008, Neurology.

[28]  H. Petereit,et al.  Expansion of antibody reactivity in the cerebrospinal fluid of multiple sclerosis patients – follow-up and clinical implications , 2005, Cerebrospinal Fluid Research.

[29]  H. Reiber,et al.  The intrathecal, polyspecific and oligoclonal immune response in multiple sclerosis , 1998, Multiple sclerosis.

[30]  V. Chan.  Epigenetics in Multiple Sclerosis. , 2020, Advances in experimental medicine and biology.

[31]  T. Olsson,et al.  Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis , 2017, Nature Reviews Neurology.

[32]  G. Akman-Demir,et al.  The MRZ reaction as a highly specific marker of multiple sclerosis: re-evaluation and structured review of the literature , 2016, Journal of Neurology.